Literature DB >> 19482692

Regulation of mu-opioid receptors by cytokines.

Jurgen Kraus1.   

Abstract

Opioids are the most potent analgesics. However, their clinical use is limited by side effects like respiratory depression and their high potential for abuse. In addition, they modulate immune functions and cause immunosuppression. Effects of clinically important opioids like morphine are mediated by the mu-opioid receptor. Knowledge about the mechanisms controling the expression of the mu-opioid receptor gene in neuronal and immune cells is crucial to understand the dynamics and the activity of this receptor. Cytokines, mediators typically released from cells of the immune system, are potent regulators of mu-opioid receptor gene expression. This emphazises the importance of mu-opioid receptors in the neuro-immune-crosstalk and their role as a molecular basis for such interactions. In this review, the up-regulation of human mu-opioid receptor gene expression in neuronal and immune effector cells by interleukin-1, interleukin-4, interleukin-6 and tumor necrosis factor, as well as its down-regulation by interferon-gamma and granulocyte/macrophage colony-stimulating factor will be summarized along with molecular mechanisms, such as transcription factor-promoter-interactions. In addition, the physiological importance of these regulatory events will be discussed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19482692     DOI: 10.2741/s16

Source DB:  PubMed          Journal:  Front Biosci (Schol Ed)        ISSN: 1945-0516


  17 in total

Review 1.  Mu opioids and their receptors: evolution of a concept.

Authors:  Gavril W Pasternak; Ying-Xian Pan
Journal:  Pharmacol Rev       Date:  2013-09-27       Impact factor: 25.468

2.  Sex differences in μ-opioid receptor expression in trigeminal ganglia under a myositis condition in rats.

Authors:  X Zhang; Y Zhang; J Asgar; K Y Niu; J Lee; K S Lee; M Schneider; J Y Ro
Journal:  Eur J Pain       Date:  2013-06-25       Impact factor: 3.931

3.  Chronic morphine consumption increase allograft rejection rate in rat through inflammatory reactions.

Authors:  Ali Rafati; Sommaye Hamzehie Taj; Negar Azarpira; Assadollah Zarifkar; Ali Noorafshan; Parvaneh Najafizadeh
Journal:  Iran Biomed J       Date:  2011

4.  Morphine stimulates cancer progression and mast cell activation and impairs survival in transgenic mice with breast cancer.

Authors:  J Nguyen; K Luk; D Vang; W Soto; L Vincent; S Robiner; R Saavedra; Y Li; P Gupta; K Gupta
Journal:  Br J Anaesth       Date:  2014-05-26       Impact factor: 9.166

Review 5.  Epigenetics of µ-opioid receptors: intersection with HIV-1 infection of the central nervous system.

Authors:  Patrick M Regan; Rajnish S Dave; Prasun K Datta; Kamel Khalili
Journal:  J Cell Physiol       Date:  2012-07       Impact factor: 6.384

Review 6.  Influence of opioids on immune function in patients with cancer pain: from bench to bedside.

Authors:  Jason W Boland; A Graham Pockley
Journal:  Br J Pharmacol       Date:  2017-07-23       Impact factor: 8.739

7.  A role for reactive oxygen species in endotoxin-induced elevation of MOR expression in the nervous and immune systems.

Authors:  Erik F Langsdorf; Xin Mao; Sulie L Chang
Journal:  J Neuroimmunol       Date:  2011-06-17       Impact factor: 3.478

Review 8.  Behavioral and molecular evidence for a feedback interaction between morphine and HIV-1 viral proteins.

Authors:  Sulie L Chang; Kaitlyn P Connaghan
Journal:  J Neuroimmune Pharmacol       Date:  2011-11-15       Impact factor: 4.147

Review 9.  The HIV-1 transgenic rat model of neuroHIV.

Authors:  Michael Vigorito; Kaitlyn P Connaghan; Sulie L Chang
Journal:  Brain Behav Immun       Date:  2015-02-27       Impact factor: 7.217

10.  Methionine enkephalin (MENK) improved the functions of bone marrow-derived dendritic cells (BMDCs) loaded with antigen.

Authors:  Weiwei Li; Jingjuan Meng; Xuan Li; Hui Hua; Meng Yiming; Qiushi Wang; Enhua Wang; Fengping Shan
Journal:  Hum Vaccin Immunother       Date:  2012-08-21       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.